Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent.

Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent. Abstract Text:

Byron C Calhoun,Elizabeth Shadigian,Brent Rooney,Byron C Calhoun,Elizabeth Shadigian,Brent Rooney,

OBJECTIVE: To investigate the human and monetary cost consequences of preterm delivery as related to induced abortion (IA), with its impact on informed consent and medical malpractice. STUDY DESIGN: A review of the literature in English was performed to assess the effect of IA on preterm delivery rates from 24 to 31 6/7 weeks to assess the risk for preterm birth attributable to IA. After calculating preterm birth risk, the increased initial neonatal hospital costs and cerebral palsy (CP) risks related to IA were calculated. RESULTS: IA increased the early preterm delivery rate by 31.5%, with a yearly increase in initial neonatal hospital costs related to IA of > $1.2 billion. The yearly human cost includes 22,917 excess early preterm births (EPB) (< 32 weeks) and 1096 excess CP cases in very-low-birth-weight newborns, <1500 g. CONCLUSION: IA contributes to significantly increased neonatal health costs by causing 31.5% of EPB. Providers of obstetric care and abortion should be aware of the risk of preterm birth attributable to induced abortion, with its significant increase in initial neonatal hospital costs and CP cases.

Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent. Publishing Authors By Initials

BC Calhoun,E Shadigian,B Rooney,BC Calhoun,E Shadigian,B Rooney,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Journal of reproductive medicine

VOLUME: 52

Page Numbers: 929-37

Journal Abbreviation:

ISSN: 0024-7758

DAY: 5

MONTH: Oct

YEAR: 2007

Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 173343

Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent.

AFFILIATION: Department of Obstetrics, West Virginia University, Charleston 25302, USA. iglu7350@mypacks.net

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Reprod Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent Related Publications

• A high-performance liquid chromatography-mass spectrometry method using a novel atmospheric pressure chemical ionization approach for the rapid simultaneous measurement of tacrolimus and cyclosporin in whole blood.
• Amyloidosis in a cow.
• An NHI alternative.
• Aortic valve replacement with simultaneous chest wall reconstruction for radiation-induced sarcoma.
• Case of lipodystrophy.
• Characterization of a novel gene for strain typing reveals substructuring of Aspergillus fumigatus across North America.
• Cost consequences of induced abortion as an attributable risk for preterm birth and impact on informed consent.
• Early thimerosal exposure and neuropsychological outcomes.
• Emergency endovascular stent graft repair of aorto-bronchial fistulas postcoarctation repair.
• Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.
• Expansion of EBV latent membrane protein 2a specific cytotoxic T cells for the adoptive immunotherapy of EBV latency type 2 malignancies: influence of recombinant IL12 and IL15.
• Exploiting cytokine secretion to rapidly produce multivirus-specific T cells for adoptive immunotherapy.
• Factors associated with improving success rates with gamete intrafallopian transfer under thin-needle spinal anesthesia.
• Further work on the cryopreservation of articular cartilage with particular reference to the liquidus tracking (LT) method.
• Hyperparathyroidism.
• Immune therapy for EBV infections after hemopoietic stem-cell transplant.
• Incorporating injured employee outcomes into physical and occupational therapists' practice: a controlled trial of the Worker-Based Outcomes Assessment System.
• Lieutenant-Colonel JFF Rooney.
• Mediastinal lipoma; the successful removal of 1,700 gram mass; case report and review of recent literature of intrathoracic lipomas.
• Mitral and tricuspid valve surgery in homozygous sickle cell disease: perioperative considerations for a successful outcome.
• Nature is changing in more ways than one.
• Prepaid dental care for Social Service recipients.
• Report of Committee on Necrology, 1902.
• Rhabdomyomatosis in the heart of the guinea pig.
• Rotation osteotomy of the tibia after poliomyelitis. A review of 51 patients.
• Small, flat colorectal cancers in the UK population: an analysis of resected specimens.
• Suicide genes as safety switches in T lymphocytes.
• T cell therapies.
• The reliability of sterilising Esmarch bandages.
• Vesicoureteral reflux in children.